ArticleJournal of experimental & clinical cancer research : CR2013

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort.

Marcello Maugeri-Saccà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.